Free Trial
CVE:IPA

ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis

ImmunoPrecise Antibodies logo
C$6.50 +0.05 (+0.78%)
As of 11/25/2022

About ImmunoPrecise Antibodies Stock (CVE:IPA)

Key Stats

Today's Range
C$6.19
C$6.70
50-Day Range
C$6.50
C$6.50
52-Week Range
C$4.52
C$8.81
Volume
19,980 shs
Average Volume
19,376 shs
Market Capitalization
C$162.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Remove Ads
Receive IPA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.

IPA Stock News Headlines

ImmunoPrecise Antibodies price target lowered to $5 from $7 at H.C. Wainwright
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
IPA and Ribopro form mRNA antibody discovery collaboration
ImmunoPrecise Antibodies Ltd IPA
See More Headlines

IPA Stock Analysis - Frequently Asked Questions

ImmunoPrecise Antibodies' stock was trading at C$6.50 at the start of the year. Since then, IPA shares have increased by 0.0% and is now trading at C$6.50.
View the best growth stocks for 2025 here
.

Shares of IPA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that ImmunoPrecise Antibodies investors own include Kraken Robotics (PNG), Facedrive (FDVRF), TrueContext (PFM), UGE International (UGE), Xebec Adsorption Inc. (XBC.V) (XBC.V), Automatic Data Processing (ADP) and Atlas Engineered Products (AEP).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:IPA
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$19.47 million
Cash Flow
C$0.77 per share
Price / Cash Flow
8.39
Book Value
C$2.67 per share
Price / Book
2.44

Miscellaneous

Free Float
N/A
Market Cap
C$162.08 million
Optionable
Not Optionable
Beta
N/A
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (CVE:IPA) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners